Utilization patterns of second-generation androgen receptor pathway inhibitors as first-line therapy for prostate cancer in the United StatesAugust 16, 2026
Why cancer, not cost of living, may be the biggest issue in Iowa’s midterm elections | IowaAugust 16, 2026
Share Facebook Twitter LinkedIn Pinterest WhatsApp Email RESEARCH HIGHLIGHT 20 February 2026 Researchers show that in mice, tumor-secreted cystatin-C crosses the blood–brain barrier and stimulates microglia to degrade amyloid plaques, which opens interesting avenues for translational clinical studies. alleviates Alzheimers Disease pathology protein tumorsecreted
Utilization patterns of second-generation androgen receptor pathway inhibitors as first-line therapy for prostate cancer in the United StatesAugust 16, 2026
MICAL2 as a key effector of β-catenin signaling driving melanoma progression and therapeutic resistanceAugust 16, 2026
Spatial analysis of head and neck cancer identifies two ecosystems with distinct modes of epithelial-to-mesenchymal transitionAugust 16, 2026